Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron orodispersible film for prevention of radiotherapy-induced vomiting in pediatric cancer patients
ChiCTR2400093665Phase 4Not yet recruiting
- Sponsor
- Chongqing University Cancer Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ondansetron in Vomiting (2 arms), sponsored by Chongqing University Cancer Hospital. Primary endpoint: Effectiveness evaluation. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
Vomiting
Beyond the preview
Go deeper on ChiCTR2400093665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093665.